Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics (Q39781545)

From Wikidata

Jump to navigation Jump to search

scientific article published on April 1997

edit

Language	Label	Description	Also known as
English	Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics	scientific article published on April 1997

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

507964

retrieved

14 September 2017

review article

1 reference

stated in

Europe PubMed Central

title

Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

507964

retrieved

14 September 2017

author name string

B S Coller

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

507964

retrieved

14 September 2017

language of work or name

English

0 references

publication date

1 April 1997

1 reference

stated in

Europe PubMed Central

PMC publication ID

507964

retrieved

14 September 2017

published in

Journal of Clinical Investigation

1 reference

stated in

Europe PubMed Central

PMC publication ID

507964

retrieved

14 September 2017

volume

99

1 reference

stated in

Europe PubMed Central

PMC publication ID

507964

retrieved

14 September 2017

issue

7

1 reference

stated in

Europe PubMed Central

PMC publication ID

507964

retrieved

14 September 2017

page(s)

1467-1471

1 reference

stated in

Europe PubMed Central

PMC publication ID

507964

retrieved

14 September 2017

cites work

Adhesion of platelets to surface-bound fibrinogen under flow

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507964

retrieved

22 September 2017

Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507964

retrieved

22 September 2017

Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507964

retrieved

22 September 2017

Studies of activated GPIIb/IIIa receptors on the luminal surface of adherent platelets. Paradoxical loss of luminal receptors when platelets adhere to high density fibrinogen

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507964

retrieved

22 September 2017

Glanzmann thrombasthenia: new insights from an historical perspective.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507964

retrieved

22 September 2017

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507964

retrieved

22 September 2017

Blockade of Platelet GPIIb/IIIa Receptors as an Antithrombotic Strategy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507964

retrieved

22 September 2017

Platelets and thrombolytic therapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507964

retrieved

22 September 2017

Rheological aspects of thrombosis and haemostasis: basic principles and applications. ICTH-Report--Subcommittee on Rheology of the International Committee on Thrombosis and Haemostasis.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507964

retrieved

15 June 2018

Platelet accumulation in experimental angioplasty: time course and relation to vascular injury

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507964

retrieved

15 June 2018

Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb/IIIa receptor antagonist, in healthy men

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507964

retrieved

2 December 2018

Thrombosis and inflammation as multicellular processes: significance of cell-cell interactions

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9119988

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9119988

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9119988

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro effects of the platelet glycoprotein IIb/IIIa receptor antagonist c7E3 Fab on the activated clotting time

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9119988

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of normal, thrombasthenic, and Bernard-Soulier platelets with immobilized fibrinogen: defective platelet-fibrinogen interaction in thrombasthenia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9119988

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of nonthrombogenicity of injured rabbit aortas despite inhibition of platelet adherence

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9119988

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9119988

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9119988

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9119988

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9119988

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial). Evaluation of c7E3 Fab in the Prevention of Ischemic Complicatio

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9119988

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9119988

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1172/JCI119307

1 reference

stated in

Europe PubMed Central

PMC publication ID

507964

retrieved

14 September 2017

PMC publication ID

507964

1 reference

stated in

Europe PubMed Central

PMC publication ID

507964

retrieved

14 September 2017

PubMed publication ID

9119988

1 reference

stated in

Europe PubMed Central

PMC publication ID

507964

retrieved

14 September 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39781545&oldid=2090300203"